• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用超临界抗溶剂(SAS)法制备熊果酸纳米粒的理化性质及口服生物利用度

Physicochemical properties and oral bioavailability of ursolic acid nanoparticles using supercritical anti-solvent (SAS) process.

作者信息

Yang Lei, Sun Zhen, Zu Yuangang, Zhao Chunjian, Sun Xiaowei, Zhang Zhonghua, Zhang Lin

机构信息

Key Laboratory of Forest Plant Ecology, Ministry of Education, Northeast Forestry University, 150040 Harbin, PR China.

Key Laboratory of Forest Plant Ecology, Ministry of Education, Northeast Forestry University, 150040 Harbin, PR China.

出版信息

Food Chem. 2012 May 1;132(1):319-25. doi: 10.1016/j.foodchem.2011.10.083. Epub 2011 Oct 31.

DOI:10.1016/j.foodchem.2011.10.083
PMID:26434296
Abstract

The objective of the study was to prepare ursolic acid (UA) nanoparticles using the supercritical anti-solvent (SAS) process and evaluate its physicochemical properties and oral bioavailability. The effects of four process variables, pressure, temperature, drug concentration and drug solution flow rate, on drug particle formation during SAS process, were investigated. Particles with mean particle size ranging from 139.2±19.7 to 1039.8±65.2nm were obtained by varying the process parameters. The UA was characterised by scanning electron microscopy, X-ray diffraction, Fourier-transform infrared spectroscopy, thermal gravimetric analysis, specific surface area, dissolution test and bioavailability test. It was concluded that physicochemical properties and bioavailability of crystalline UA could be improved by physical modification, such as particle size reduction and generation of amorphous state using SAS process. Further, SAS process was a powerful methodology for improving the physicochemical properties and bioavailability of UA.

摘要

本研究的目的是采用超临界抗溶剂(SAS)工艺制备熊果酸(UA)纳米颗粒,并评估其理化性质和口服生物利用度。研究了压力、温度、药物浓度和药物溶液流速这四个工艺变量对SAS过程中药物颗粒形成的影响。通过改变工艺参数,获得了平均粒径范围为139.2±19.7至1039.8±65.2nm的颗粒。通过扫描电子显微镜、X射线衍射、傅里叶变换红外光谱、热重分析、比表面积、溶出度试验和生物利用度试验对UA进行了表征。得出结论,通过物理改性,如使用SAS工艺减小粒径和生成无定形状态,可以改善结晶UA的理化性质和生物利用度。此外,SAS工艺是一种改善UA理化性质和生物利用度的有效方法。

相似文献

1
Physicochemical properties and oral bioavailability of ursolic acid nanoparticles using supercritical anti-solvent (SAS) process.采用超临界抗溶剂(SAS)法制备熊果酸纳米粒的理化性质及口服生物利用度
Food Chem. 2012 May 1;132(1):319-25. doi: 10.1016/j.foodchem.2011.10.083. Epub 2011 Oct 31.
2
Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process.采用喷雾干燥法和超临界抗溶剂沉淀法制备的非晶态阿托伐他汀半钙盐的理化性质及口服生物利用度
Int J Pharm. 2008 Jul 9;359(1-2):211-9. doi: 10.1016/j.ijpharm.2008.04.006. Epub 2008 Apr 12.
3
Experimental investigation and oral bioavailability enhancement of nano-sized curcumin by using supercritical anti-solvent process.采用超临界抗溶剂法对纳米姜黄素进行实验研究及提高其口服生物利用度
Eur J Pharm Biopharm. 2015 Oct;96:162-72. doi: 10.1016/j.ejpb.2015.07.021. Epub 2015 Aug 1.
4
Ursolic acid nanoparticles for oral delivery prepared by emulsion solvent evaporation method: characterization, in vitro evaluation of radical scavenging activity and bioavailability.乳液溶剂蒸发法制备的熊果酸纳米粒口服给药:特性、自由基清除活性的体外评价和生物利用度。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):610-621. doi: 10.1080/21691401.2019.1573739.
5
Preparation, characterization and in vivo assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process.超临界抗溶剂法制备、表征及体内评价甘草酸微球的生物利用度。
Int J Pharm. 2012 Feb 28;423(2):471-9. doi: 10.1016/j.ijpharm.2011.12.007. Epub 2011 Dec 13.
6
Preparation of ursolic acid-phospholipid complex by solvent-assisted grinding method to improve dissolution and oral bioavailability.溶剂辅助研磨法制备熊果酸-磷脂复合物以提高其溶解性能和口服生物利用度。
Pharm Dev Technol. 2020 Jan;25(1):68-75. doi: 10.1080/10837450.2019.1671864. Epub 2019 Oct 1.
7
Preparation and physicochemical properties of vinblastine microparticles by supercritical antisolvent process.超临界抗溶剂法制备长春碱微粒及其理化性质
Int J Mol Sci. 2012 Oct 3;13(10):12598-607. doi: 10.3390/ijms131012598.
8
Ursolic Acid Nanocrystals for Dissolution Rate and Bioavailability Enhancement: Influence of Different Particle Size.熊果酸纳米晶体提高溶出速率和生物利用度:不同粒径的影响
Curr Drug Deliv. 2016;13(8):1358-1366. doi: 10.2174/1567201813666160307142757.
9
Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.采用超临界抗溶剂(SAS)法制备、表征及体内评价无定形阿托伐他汀钙纳米粒
Eur J Pharm Biopharm. 2008 Jun;69(2):454-65. doi: 10.1016/j.ejpb.2008.01.007. Epub 2008 Jan 18.
10
Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.通过液体反溶剂沉淀技术提高花旗松素纳米颗粒的溶解度、抗氧化能力和生物利用度。
Int J Pharm. 2014 Aug 25;471(1-2):366-76. doi: 10.1016/j.ijpharm.2014.05.049. Epub 2014 Jun 2.

引用本文的文献

1
Advances in the chemo‑preventive effects and mechanisms of ursolic acid against lung cancer (Review).熊果酸对肺癌的化学预防作用及机制研究进展(综述)
Oncol Rep. 2025 Oct;54(4). doi: 10.3892/or.2025.8959. Epub 2025 Aug 1.
2
Improving anti-oxidant stress treatment of subarachnoid hemorrhage through self-assembled nanoparticles of oleanolic acid.通过齐墩果酸自组装纳米粒改善蛛网膜下腔出血的抗氧化应激治疗。
Drug Deliv. 2024 Dec;31(1):2388735. doi: 10.1080/10717544.2024.2388735. Epub 2024 Aug 21.
3
Mechanistic Insights of Polyphenolic Compounds from Rosemary Bound to Their Protein Targets Obtained by Molecular Dynamics Simulations and Free-Energy Calculations.
通过分子动力学模拟和自由能计算获得的迷迭香中多酚类化合物与其蛋白质靶点结合的机制见解。
Foods. 2023 Jan 14;12(2):408. doi: 10.3390/foods12020408.
4
Particle preparation of pharmaceutical compounds using supercritical antisolvent process: current status and future perspectives.采用超临界抗溶剂法制备药物化合物的颗粒:现状和未来展望。
Drug Deliv Transl Res. 2023 Apr;13(4):946-965. doi: 10.1007/s13346-022-01283-7. Epub 2022 Dec 27.
5
Evidence of the Beneficial Effects of Ursolic Acid against Lung Cancer.熊果酸抑制肺癌作用的证据。
Molecules. 2022 Nov 2;27(21):7466. doi: 10.3390/molecules27217466.
6
Therapeutic Potential of Ursolic Acid in Cancer and Diabetic Neuropathy Diseases.熊果酸在癌症和糖尿病性神经病疾病中的治疗潜力。
Int J Mol Sci. 2021 Nov 10;22(22):12162. doi: 10.3390/ijms222212162.
7
Nanoformulations of Ursolic Acid: A Modern Natural Anticancer Molecule.熊果酸的纳米制剂:一种现代天然抗癌分子
Front Pharmacol. 2021 Jul 5;12:706121. doi: 10.3389/fphar.2021.706121. eCollection 2021.
8
Ursolic and Oleanolic Acids: Plant Metabolites with Neuroprotective Potential.熊果酸和齐墩果酸:具有神经保护潜力的植物代谢物。
Int J Mol Sci. 2021 Apr 27;22(9):4599. doi: 10.3390/ijms22094599.
9
Different Forms of Ursolic Acid and Their Effect on Liver Regeneration.熊果酸的不同形式及其对肝脏再生的影响。
Evid Based Complement Alternat Med. 2020 Jul 26;2020:4074068. doi: 10.1155/2020/4074068. eCollection 2020.
10
Potential Albumin-Based Antioxidant Nanoformulations for Ocular Protection against Oxidative Stress.用于眼部抗氧化应激保护的潜在基于白蛋白的抗氧化纳米制剂。
Pharmaceutics. 2019 Jun 26;11(7):297. doi: 10.3390/pharmaceutics11070297.